vimarsana.com

Page 47 - ப்ரொடக்ஶந் இணைக்கப்பட்டுள்ளது ஊக்கத்தொகை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

How technology is making CDMOs more efficient for vaccine development?

Amara Raja Batteries bucks Covid blues, logs strong growth across verticals in FY21

Amara Raja Batteries bucks Covid blues, logs strong growth across verticals in FY21 May 25, 2021 Awaits PLI scheme for new plan Amara Raja Batteries Limited registered a strong performance in FY21 bucking the disruption caused by the Covid pandemic lockdown by registering a strong volume growth across verticals. Growth was aided by volumes in both automotive and industrial applications across all customer segments. These sectors witnessed better- than-expected demand in the last two quarters of the last financial year. The batteries major posted a profit of ₹646.83 crore and income of ₹7237.14 crore for FY21. The company completed expansion of capacities in 4Ws/2Ws (by 1.5m/3m units to 14m/20m units) and is expected to deploy a capex of about ₹400-450 crore in FY22, according to Motilal Oswal.

Automation can build industry s immunity against Covid-19 - The Hindu BusinessLine

Manufacturing is looking for more automation India’s manufacturing is struggling to breathe during the second wave of the Covid-19 virus. Before the pandemic, the sector was estimated to contribute 25 per cent to the country’s GDP by 2025. The Central Government’s ‘Make in India’ and ‘Atmanirbhar Bharat’ initiatives signalled to the world that becoming a global manufacturing hub was a top priority. The 2021 Union Budget’s Production Linked Incentive (PLI) Scheme to boost local manufacturing attracted three of Apple’s top manufacturers to India Foxconn, Wistron, and Pegatron.Nineteen global and 14 domestic companies have filed under the PLI scheme. The economy was picking up that is before the second wave hit. Once again, manufacturers today are facing great uncertainty. Employees continue to succumb to the virus, and states are imposing varying levels of restrictions some instituting total lockdowns. And with experts anticipating a third wave, why isn’t ma

Drugmakers cry monopoly as Modi govt picks 1 firm each to make over 20 key raw materials

Drugmakers cry ‘monopoly’ as Modi govt picks 1 firm each to make over 20 key raw materials Himani Chandna © Provided by The Print New Delhi: India’s weapon to fight its dependence on Chinese medicine imports the Production-Linked Incentive scheme may end up creating a monopoly of just a few drugmakers, and the pharma lobby has expressed its concern about this to the Narendra Modi government. The PLI scheme launched by the government in July provides monetary incentives to increase the production of 41 critical raw materials, including active pharmaceutical ingredients (APIs), intermediates and key starting materials, distributed in four categories, that are required for manufacturing final formulations (medicines) in India.

Ministry of External Affairs of the Republic[ ] (via Public) / Speech by External Affairs Minister at the Future of Asia Conference organized by Nikkei

Ministry of External Affairs of the Republic[ ] (via Public) / Speech by External Affairs Minister at the Future of Asia Conference organized by Nikkei
publicnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publicnow.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.